[18F] Fluoromisonidazole PET in rectal cancer
Background: There is an increasing interest in developing predictive biomarkers of tissue hypoxia using functional imaging for personalised radiotherapy in patients with rectal cancer that are considered for neoadjuvant chemoradiotherapy (CRT). The study explores [18F]fluoromisonidazole ([18F]FMISO) positron emission tomography (PET) scans for predicting clinical response in rectal cancer patients receiving neoadjuvant CRT.
Methods: Patients with biopsy-proven rectal adenocarcinoma...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 6.5MB)
- Publisher copy:
- Copyright holder:
- © Puri, et al 2017
- Copyright date:
- This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record